ArticlePharmacology research & perspectives2025
Roadmap and Reflections on Expanding Equity, Diversity, Inclusion, Indigeneity, and Accessibility in Pharmacology Curricula.
Article in Pharmacology research & perspectives, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nurturing learning systems that are respectful and welcoming to diverse individuals is a step towards improving the experience of all students in pharmacology and toxicology (Pharm-Tox). This paper evaluates the Pharm-Tox curriculum at the University of Toronto with a critical lens towards the incorporation of content that is Equitable, Diverse, Inclusive, acknowledges Indigeneity, and is Accessible (EDIIA). A curriculum mapping approach examined the undergraduate Pharm-Tox curriculum to identify EDIIA gaps and areas for improvement. Key stakeholders that contributed to the curriculum mapping process were undergraduate students, teaching faculty, and an external research associate who identified EDIIA themes used to evaluate existing course materials. The curriculum map identified areas to improve EDIIA integration in individual courses and resulted in the design of course-specific recommendations. Centrally housed department resources were also developed to mitigate barriers to faculty implementation of the EDIIA recommendations. These resources included an internal EDIIA handbook on appropriate language in the classroom, a guide to creating accessible and inclusive PowerPoint slides, and a pre-course survey to identify the student population and their needs. Resources were well received by faculty, and to assess the impact of EDIIA recommendations on student learning, ongoing review of curricular changes will be conducted through student surveys. The recommendations from this curriculum mapping process encourage faculty to explore opportunities for EDIIA integration in the undergraduate Pharm-Tox curriculum with the goal of strengthening the existing curriculum and improving the student learning experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.